SUZ12 (Suppressor of zeste 12) is a protein that plays a crucial role in the regulation of gene expression through histone modification. It is a key component of the Polycomb repressive complex 2 (PRC2), which is involved in the silencing of genes through histone methylation.
Overexpression of SUZ12 has been observed in many types of cancer, and it is often associated with poor prognosis and reduced survival rates.
Direction of Regulation in Cancer
Context-dependent, with two dominant patterns:
A. Functionally UPREGULATED (most common)
-PRC2 activity is increased (often via EZH2 overactivity, but SUZ12 is required)
-Results in excessive H3K27me3
-Locks down tumor suppressor and differentiation genes
B. Loss-of-function in select cancers
-SUZ12 deletions or inactivating alterations occur in specific tumor types
-Leads to epigenetic instability and aberrant gene activation
Thus, SUZ12 can behave as an oncogenic enabler or a tumor suppressor, depending on context.
SUZ12 is a contextual epigenetic biomarker that defines whether PRC2 repression is intact. Its loss acts as a negative predictive marker for PRC2/EZH2 dependency, while its presence enables EZH2-driven biology. SUZ12 rarely changes management alone, but it is essential for correct interpretation of EZH2 and Polycomb-targeted strategies.
|